Literature DB >> 29904312

Secondary involvement of the gastrointestinal tract by renal cell carcinoma.

Daniel S Grosser1, He Huang1.   

Abstract

Secondary involvement of the gastrointestinal (GI) tract by renal cell carcinoma is rare. We undertook a retrospective review of our institution's pathology records from January 2006 to July 2017 and identified eight cases of GI tract involvement by renal cell carcinoma. Sites of involvement included stomach, duodenum, jejunum, ileum, and cecum. Pertinent clinical information was obtained from electronic medical records. The interval from primary resection to identification of GI involvement was often prolonged, averaging 6 years, and mimicked primary GI tract malignancies, with presentations including GI bleeding, abdominal pain, and obstruction. One case presented asymptomatically on follow-up imaging. Histologic patterns of involvement varied from classic clear cell to purely sarcomatoid or complex unclassifiable morphology. Two patients with tumors exhibiting sarcomatoid morphology died within 2 years of primary resection and <1 year of GI involvement. The remaining patients survived a mean of 9 years (range, 5 to 22 years) at their last available follow-up.

Entities:  

Keywords:  Gastrointestinal tract; renal cell carcinoma; secondary involvement

Year:  2018        PMID: 29904312      PMCID: PMC5997044          DOI: 10.1080/08998280.2018.1463038

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  10 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  PAX2 and PAX8 expression in primary and metastatic müllerian epithelial tumors: a comprehensive comparison.

Authors:  Ayhan Ozcan; Nathan Liles; Donna Coffey; Steven S Shen; Luan D Truong
Journal:  Am J Surg Pathol       Date:  2011-12       Impact factor: 6.394

Review 3.  Immunohistochemical diagnosis of renal neoplasms.

Authors:  Luan D Truong; Steven S Shen
Journal:  Arch Pathol Lab Med       Date:  2011-01       Impact factor: 5.534

4.  Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma.

Authors:  Badar M Mian; Nishin Bhadkamkar; Joel W Slaton; Peter W T Pisters; Danai Daliani; David A Swanson; Louis L Pisters
Journal:  J Urol       Date:  2002-01       Impact factor: 7.450

5.  Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent.

Authors:  Megan M Merrill; Christopher G Wood; Nizar M Tannir; Rebecca S Slack; Kara N Babaian; Eric Jonasch; Lance C Pagliaro; Zachary Compton; Pheroze Tamboli; Kanishka Sircar; Louis L Pisters; Surena F Matin; Jose A Karam
Journal:  Urol Oncol       Date:  2015-02-17       Impact factor: 3.498

6.  Distribution of metastatic sites in renal cell carcinoma: a population-based analysis.

Authors:  M Bianchi; M Sun; C Jeldres; S F Shariat; Q-D Trinh; A Briganti; Z Tian; J Schmitges; M Graefen; P Perrotte; M Menon; F Montorsi; P I Karakiewicz
Journal:  Ann Oncol       Date:  2011-09-02       Impact factor: 32.976

7.  Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy.

Authors:  R A Rabinovitch; M J Zelefsky; J J Gaynor; Z Fuks
Journal:  J Clin Oncol       Date:  1994-01       Impact factor: 44.544

8.  Metastatic gastric tumors arising from renal cell carcinoma: Clinical characteristics and outcomes of this uncommon disease.

Authors:  Tsutomu Namikawa; Masaya Munekage; Hiroyuki Kitagawa; Takehiro Okabayashi; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Oncol Lett       Date:  2012-07-17       Impact factor: 2.967

9.  The ISUP system of staging, grading and classification of renal cell neoplasia.

Authors:  Hemamali Samaratunga; Troy Gianduzzo; Brett Delahunt
Journal:  J Kidney Cancer VHL       Date:  2014-07-20

10.  Gastrointestinal Involvement of Recurrent Renal Cell Carcinoma: CT Findings and Clinicopathologic Features.

Authors:  Hyo Jung Park; Hyun Jin Kim; Seong Ho Park; Jong Seok Lee; Ah Young Kim; Hyun Kwon Ha
Journal:  Korean J Radiol       Date:  2017-04-03       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.